Cargando…
Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2
Oral squamous cell carcinoma (OSCC) is a lethal disease with a 5-year mortality rate of around 50%. Molecular targeted therapies are not in routine use and novel therapeutic targets are required. Our previous microarray data indicated sphingosine 1-phosphate (S1P) metabolism and signalling was dereg...
Autores principales: | Patmanathan, Sathya Narayanan, Johnson, Steven P., Lai, Sook Ling, Panja Bernam, Suthashini, Lopes, Victor, Wei, Wenbin, Ibrahim, Maha Hafez, Torta, Federico, Narayanaswamy, Pradeep, Wenk, Markus R., Herr, Deron R., Murray, Paul G., Yap, Lee Fah, Paterson, Ian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861980/ https://www.ncbi.nlm.nih.gov/pubmed/27160553 http://dx.doi.org/10.1038/srep25650 |
Ejemplares similares
-
Sphingosine-1-phosphate lyase (SGPL1) deficiency is associated with mitochondrial dysfunction
por: Maharaj, A., et al.
Publicado: (2020) -
The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod
por: Patmanathan, Sathya Narayanan, et al.
Publicado: (2015) -
SGPL1 stimulates VPS39 recruitment to the mitochondria in MICU1 deficient cells
por: Jackson, Joshua, et al.
Publicado: (2022) -
Nephrotic syndrome and adrenal insufficiency caused by a variant in SGPL1
por: Linhares, Natália Duarte, et al.
Publicado: (2018) -
SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production
por: Mitroi, Daniel N., et al.
Publicado: (2017)